glp-1 usage statistics Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline The Multi-Sector Impacts of GLP-1RA

Its being studied for depression, OCD, addiction, and neurodegenerative diseases

Appetite and food reward 3-arm Phase 1 tirzepatide vs liraglutide 3.0 mg vs placebo: measured lunch intake fell 524.6 kcal vs placebo by week 3 (about 72% by week 6), with craving and hedonic-hunger reductions exceeding liraglutide

These inhibitors represent a more conservative pharmaceutical approach compared to GLP-1 receptor agonists like semaglutide (Ozempic)

it's a commitment to your skin's future, promising a brighter, clearer, and younger-looking complexion

Lots of celebrities and influential figures have been using these drugs for a while